Maynard Um
-
-
-
-
-
-
-
Biofrontera files FDA application for skin cancer treatment
-
-
-
-
-
-
-
Biofrontera (BFRI) Will Profit from $11 Million Financing Agreement: Benchmark
-
-
-
-
-
-
-
Benchmark Reiterates Buy Rating on Biofrontera (BFRI)
-
-
-
-
-
-
-
Biofrontera (BFRI) Announces Database Lock Of Phase 3 Study Of Ameluz-Photodynamic Therapy In The Treatment Of sBCC
-
-
-
-
-
-
-
Roth/MKM Reiterates Buy Rating on Biofrontera (BFRI)
404,859 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

